Anzeige
Mehr »
Donnerstag, 14.05.2026 - Börsentäglich über 12.000 News
Bahnbrechende KI-Lösung "Ohne Nadelstiche" als Ersatz für herkömmliche Bluttests "unlocked"?!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von FiercePharma

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
FrDaiichi Sankyo takes $610M profit hit linked to ADC manufacturing overbuild
FrAbbVie's Skyrizi beats out J&J's Tremfya in in April drug ad spending leaderboard
FrJohnson & Johnson launches 'Generation Fine' depression project
FrRevisiting Pharma's tariff reality
FrGSK tees up a Modern Family for meningitis messaging
FrPre-launch efforts linked to lasting drug awareness edge: report
07.05.Angelini finds Catalyst for its US growth ambitions with $4.1B buyout
07.05.FDA to reconsider shock rejection of cell therapy Ebvallo. Could uniQure be next?
07.05.Insulet CEO details 'Scrubs' device promotion win as it boosts awareness, education drive
07.05.Alnylam rebuked by FDA over efficacy claims on Amvuttra website
06.05.Sanofi asks to pull Tzield bid from FDA's controversial CNPV program: report
06.05.FDA rolls out 1-day assessment pilot in bid to refocus inspection resources
06.05.Bayer diagnoses how to build trust in cell and gene therapies
06.05.Novo CEO cites pricing 'sweet spot' as Wegovy pill debuts with $355M quarter
06.05.FDA blocks publication of COVID, shingles vaccine safety studies: NYT
06.05.Touting $529B in savings over 10 years, White House looks to expand MFN deals with pharma
06.05.Novo Nordisk, Eli Lilly fined by French regulator over obesity drug promotions
06.05.Lilly to invest $4.5B more into massive Indiana manufacturing complex
05.05.After Alzheimer's agitation nod, Axsome jacks up Auvelity's peak sales projection to $8B
05.05.BioNTech to slash 1,860 jobs, exit sites in Germany and Singapore in major manufacturing pullback
05.05.Novartis to close German manufacturing site, cutting 220 jobs
05.05.Pfizer delivers strong Q1 but keeps guidance steady amid COVID seasonality
05.05.Neurocrine cites work disruption data to make case for timely movement disorder diagnosis
05.05.Sanofi expands AI capabilities, investing $294M to scale Toronto hub
05.05.Eyeing CAR-T autoimmune first, Kyverna hires pharma veteran as CCO